| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
| SMS-Oncology (Specialized Medical Services-Oncology B.V.). (7/8/19). "Press Release: SMS-Oncology Opens New Office in Frankfurt, Germany". Schiphol. |
2019-07-08 |
| Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. |
2019-07-08 |
| Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. |
2019-07-08 |
| Immatics Biotechnologies GmbH. (7/8/19). "Press Release: Immatics Appoints Harpreet Singh as Chief Executive Officer". Tübingen & Houston, TX. |
2019-07-08 |
| Evotec SE. (7/8/19). "Press Release: Evotec and Venture Capital Consortium Form Breakpoint Therapeutics GmbH". Hamburg. |
2019-07-08 |
| Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. |
2019-07-08 |
| MorphoSys AG. (7/8/19). "Press Release: MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology". Planegg & Halle (Saale). |
2019-07-08 |
| IGM Biosciences, Inc.. (7/8/19). "Press Release: IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline". |
2019-07-08 |
| PhoreMost Ltd.. (7/8/19). "Press Release: PhoreMost and inStem Enter Structural Biology Alliance". Cambridge. |
2019-07-08 |
| Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". |
2019-07-08 |
| Cobo Technologies ApS. (7/5/19). "Press Release: CRISPR Researchers to Benefit from Cobo Technologies and Sciex Partnership". Copenhagen. |
2019-07-05 |
| Kither Biotech S.r.l.. (7/5/19). "Press Release: Kither Biotech Raises a €5.6m Financing Round to Support the Clinical Development of a New Drug for Cystic Fibrosis and other Pulmonary Diseases". Turin. |
2019-07-05 |
| Nosopharm SAS. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. |
2019-07-03 |
| MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg. |
2019-07-03 |
| Confo Therapeutics N.V.. (7/3/19). "Press Release: Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-modulating Compounds". Ghent & Dresden. |
2019-07-03 |
| High-Tech Gründerfonds Management GmbH. (7/3/19). "Press Release: “First-in-Class“ mRNA-therapeutics for Vascular Diseases – Pantherna Therapeutics Receives 7-digit Investment". |
2019-07-03 |
| GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. |
2019-07-03 |
| GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. |
2019-07-03 |
| Citryll B.V.. (7/3/19). "Press Release: Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody". Oss. |
2019-07-03 |
| Evotec SE. (7/3/19). "Press Release: Evotec Completes Acquisition of Just Biotherapeutics". Hamburg. |
2019-07-03 |
| Nanoform Finland Oyj. (7/3/19). "Press Release: Nanoform Continues Strategic Growth with €10 Million Private Placement". Helsinki. |
2019-07-03 |
| Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. |
2019-07-02 |
| Oncovita SAS. (7/2/19). "Press Release: Oncovita Signs Exclusive Licensing Agreement with Institut Pasteur. Agreement Will Cover Development and Marketing of Oncolytic Virotherapies". Paris. |
2019-07-02 |
| Cancer Research UK. (7/2/19). "Press Release: Cancer Research UK Forms Collaboration with SV Health Investors to Accelerate Development of Cancer Medicines". |
2019-07-02 |
| Antibodies.com. (7/2/19). "Press Release: Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less". Cambridge. |
2019-07-02 |
| Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. |
2019-07-02 |
| AgroSavfe N.V.. (7/2/19). "Press Release: AgroSavfe Appoints Patrice Sellès as New Chief Executive Officer and further Strengthens Leadership Team". Ghent. |
2019-07-02 |
| Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg. |
2019-07-02 |
| [iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. |
2019-07-01 |
| Bayer AG. (7/1/19). "Press Release: Century Therapeutics Launches with USD 250M Financing for induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform". Leverkusen, Philadelphia, PA & Tokyo. |
2019-07-01 |
| X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. |
2019-07-01 |
| Boehringer Ingelheim. (7/1/19). "Press Release: Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline with New First-in-Class Compound from Yuhan Corporation". Ingelheim & Seoul. |
2019-07-01 |
| R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt. |
2019-07-01 |
| Photocure ASA. (7/1/19). "Press Release: Photocure and Asieris Enter into a Global Licensing Deal for Cevira with up to USD 250 Million in Milestones and Double-digit Royalties". Oslo. |
2019-07-01 |
| Ahren Innovation Capital LLP. (7/1/18). "Press Release: Ahren Announces Fund Close". |
2019-07-01 |
| Merck KGaA. (7/1/19). "Press Release: Merck Places Bonds Amounting to € 2 Billion. Issuance Is Final Key Component in the Financing of the Planned Versum Transaction". Darmstadt. |
2019-07-01 |
| ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". |
2019-07-01 |
| Illumina, Inc.. (6/28/19). "Press Release: Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US". San Diego, CA. |
2019-06-28 |
| Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. |
2019-06-28 |
| Community for Analytical Measurement Science. (6/28/19). "Press Release: Community for Analytical Measurement Science Celebrates Its Launch". London. |
2019-06-28 |
| 4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. |
2019-06-28 |
| Curetis N.V.. (6/28/19). "Press Release: Curetis Reports Results of the Annual General Meeting Held on June 27, 2019. All Proposed AGM Resolutions Approved by Shareholders". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-06-28 |
| Oncopeptides AB. (6/28/19). "Press Release: Oncopeptides Has Completed a Directed Share Issue of approximately SEK 727 Million (USD 78 M) [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]". |
2019-06-28 |
| Oncopeptides AB. (6/27/19). "Press Release: Oncopeptides Intends to Make a Directed Share Issue [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]". |
2019-06-27 |
| PhagoMed Biopharma GmbH. (6/27/19). "Press Release: Further Investment for PhagoMed. Investors Support Phage Therapy". Vienna. |
2019-06-27 |
| Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg. |
2019-06-27 |
| Polyphor Ltd.. (6/27/19). "Press Release: Polyphor Appoints Frank Weber as New Chief Medical and Development Officer". Allschwil. |
2019-06-27 |
| Modag GmbH. (6/27/19). "Press Release: Modag Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy". Wendelsheim. |
2019-06-27 |
| CryoTherapeutics GmbH / CryoTherapeutics S.A.. (6/27/19). "Press Release: CryoTherapeutics Closes Series B Financing Round at EUR 7 Million". Awans & Cologne. |
2019-06-27 |
| Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. |
2019-06-27 |
| Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire. |
2019-06-27 |
| Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
| Quanterix Corporation. (6/26/19). "Press Release: Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier". Billerica, MA. |
2019-06-26 |
| ImmunoPrecise Antibodies Ltd.. (6/26/19). "Press Release: ImmunoPrecise Guarantees Success for Customers of Their Well-established B Cell Select Antibody Discovery Platform". Victoria, BC. |
2019-06-26 |
| Evotec SE. (6/26/19). "Press Release: Evotec SE Places First Schuldschein (Promissory Note) Worth EUR 250 m". Hamburg. |
2019-06-26 |
| Oxford Sciences Innovation. (6/26/19). "Press Release: Theolytics Limited Comes Out of Stealth Mode with Dr Ken Powell Announced as Chair of the Board". |
2019-06-26 |
| Oxford Biomedica plc. (6/26/19). "Press Release: Oxford Biomedica and Santen Enter R&D Collaboration and Option & Licence Agreement for Development of Gene Therapy vectors for Inherited Retinal Disease". Oxford & Osaka. |
2019-06-26 |
| Cobra Biologics Ltd.. (6/25/19). "Press Release: Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration". Keele & Stirling. |
2019-06-25 |
| Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. |
2019-06-25 |
| Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg. |
2019-06-25 |
| Genedata AG. (6/25/19). "Press Release: Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis". Basel. |
2019-06-25 |
| Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. |
2019-06-25 |
| AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". |
2019-06-25 |
| Frontier Medicines Corporation. (6/25/19). "Press Release: Frontier Medicines Launches with $67 Million to Develop Novel Medicines that Drug the »Undruggable« Targets Driving Human Disease". South San Francisco, CA. |
2019-06-25 |
| Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility". Princeton, NJ, Cambridge, MA & Lyon. |
2019-06-24 |
| Genfit S.A.. (6/24/19). "Press Release: Genfit and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China". Lille & Cambridge, MA. |
2019-06-24 |
| MorphoSys AG. (6/24/19). "Press Release: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer". Planegg. |
2019-06-24 |
| Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies". Lyon & Cambridge, MA. |
2019-06-24 |
| Kymab Ltd.. (6/24/19). "Press Release: Kymab and LifeArc Enter Strategic Partnership to Discover New Medicines Using Kymab’s IntelliSelect Technologies". Cambridge. |
2019-06-24 |
| Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg. |
2019-06-24 |
| Arcus Biosciences, Inc.. (6/24/19). "Press Release: Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer". Hayward, CA. |
2019-06-24 |
| GlaxoSmithKline plc. (6/24/19). "Press Release: U.S. Food and Drug Administration Accepts GSK’s Application for Zejula (niraparib) in Late Stage Ovarian Cancer with Priority Review". London. |
2019-06-24 |
| Oxford Immunotec Global plc. (6/24/19). "Press Release: Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman". Oxford & Marlborough, MA. |
2019-06-24 |
| Atomwise, Inc.. (6/24/19). "Press Release: Atomwise and Enamine to Advance Pediatric Oncology with the World’s First and Largest Ten Billion Compound Virtual Screen". San Francisco, CA & Kiev. |
2019-06-24 |
| Sanofi S.A.. (6/21/19). "Press Release: Sanofi and Regeneron Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma". Paris & Tarrytown, NY. |
2019-06-21 |
| Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". |
2019-06-21 |
| Immunic, Inc.. (6/21/19). "Press Release: Immunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate Update". San Diego, CA. |
2019-06-21 |
| MGI Tech Co., Ltd.. (6/20/19). "Press Release: MGI Forms Partnership with Karolinska Institutet Centre for Translational Microbiome Research (CTMR) to Understand the Effects of Microbiome on Human Health". Shenzhen. |
2019-06-20 |
| Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. |
2019-06-20 |
| Catalent, Inc.. (6/19/19). "Press Release: Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy". New York, NY & Somerset, NJ. |
2019-06-19 |
| Lonza Group Ltd.. (6/19/19). "Press Release: Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel". Basel & Boston, MA. |
2019-06-19 |
| Hesperos, Inc.. (6/19/19). "Press Release: Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index". Orlando, FL. |
2019-06-19 |
| Genovis AB. (6/19/19). "Press Release: Genovis AB Hires CFO". |
2019-06-19 |
| Belgian Growth Fund. (6/19/19). "Press Release: BGF Starts with Initial Amount of EUR 213 Million". |
2019-06-19 |
| Dopavision GmbH. (6/19/19). "Press Release: Digital Health Startup Dopavision Raises €1.2 Million Seed Investment". |
2019-06-19 |
| Sartorius AG. (6/19/19). "Press Release: Sartorius Starts Up Operations at Expanded Site in Puerto Rico. Investment of more than 100 million U.S. Dollars – Area Designed for Future Growth". Göttingen. |
2019-06-19 |
| Sanofi S.A.. (6/18/19). "Press Release: Sanofi and Google to Develop New Healthcare Innovation Lab". Paris. |
2019-06-18 |
| BioCity Group Ltd.. (6/18/19). "Press Release: New Carbon Capture Technology Could Help Industry and Agricultural Sector Decarbonise". |
2019-06-18 |
| German Accelerator Life Sciences. (6/18/19). "Press Release: German Accelerator Appoints Marc Filerman as CEO Life Sciences". Munich & Cambridge, MA. |
2019-06-18 |
| Imcyse S.A.. (6/18/19). "Press Release: Imcyse Secures Total of €35M in Series B Financing Round and Additional Grants". Liège. |
2019-06-18 |
| Merck KGaA. (6/18/19). "Press Release: Merck Places Hybrid Bond Amounting to € 1.5 Billion. Placement Is an Important Part of the Financing of the Planned Acquisition of Versum Materials, Inc.". Darmstadt. |
2019-06-18 |
| Roche. (6/18/19). "Press Release: Japan Becomes the First Country to Approve Roche’s Personalised Medicine Rozlytrek". Basel. |
2019-06-18 |
| Owlstone Medical Ltd.. (6/18/19). "Press Release: Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease". Cambridge. |
2019-06-18 |
| Illumina, Inc.. (6/17/19). "Press Release: Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. |
2019-06-17 |
| Osteolabs GmbH. (6/17/19). "Press Release: Osteolabs GmbH Successfully Closes Seed Financing Round". Kiel. |
2019-06-17 |
| Novozymes A/S. (6/16/19). "Press Release: Strategy Update for the Three-year Period 2020-2022". |
2019-06-16 |
| GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. |
2019-06-13 |
| Spero Therapeutics, Inc.. (6/13/19). "Press Release: Spero Announces $10 Million Registered Direct Offering of Common Stock. Novo Holdings A/S through Its Novo REPAIR Impact Fund to Invest Up to $10 million". Cambridge, MA. |
2019-06-13 |
| Freeline Therapeutics Ltd.. (6/13/19). "Press Release: Freeline Announces Senior Leadership Transition and Completion of Series B Financing Milestones". |
2019-06-13 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 61 62 63 ... 68 69 70 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
